FI831420L - Tricykliska foereningar, deras framstaellning, anvaendning och mellanprodukter - Google Patents

Tricykliska foereningar, deras framstaellning, anvaendning och mellanprodukter

Info

Publication number
FI831420L
FI831420L FI831420A FI831420A FI831420L FI 831420 L FI831420 L FI 831420L FI 831420 A FI831420 A FI 831420A FI 831420 A FI831420 A FI 831420A FI 831420 L FI831420 L FI 831420L
Authority
FI
Finland
Prior art keywords
foamening
tricycle
deras framstaellning
anvaendning
mellanprodukter
Prior art date
Application number
FI831420A
Other languages
English (en)
Other versions
FI82832C (fi
FI82832B (fi
FI831420A0 (fi
Inventor
John Frederick Batchelor
Richard Martin Hyde
William Richard King
David John Livingstone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI831420A0 publication Critical patent/FI831420A0/fi
Publication of FI831420L publication Critical patent/FI831420L/fi
Priority to FI864862A priority Critical patent/FI82833C/fi
Application granted granted Critical
Publication of FI82832B publication Critical patent/FI82832B/fi
Publication of FI82832C publication Critical patent/FI82832C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI831420A 1982-04-27 1983-04-26 Foerfarande foer framstaellning av terapeutiskt anvaendbara disubstituerade xanten- och xantonderivat. FI82832C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI864862A FI82833C (fi) 1982-04-27 1986-11-28 Disubstituerade xanten- och xantonderivat och anvaendning av dessa foer uppraetthaollande av syretillfoerselfoermaogan hos upplagrade humaneretrocyter och foerlaengning av den anvaendbara upplagringstiden foer dessa.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8212139 1982-04-27
GB8212139 1982-04-27
GB8230055 1982-10-21
GB8230055 1982-10-21

Publications (4)

Publication Number Publication Date
FI831420A0 FI831420A0 (fi) 1983-04-26
FI831420L true FI831420L (fi) 1983-10-28
FI82832B FI82832B (fi) 1991-01-15
FI82832C FI82832C (fi) 1991-04-25

Family

ID=26282657

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831420A FI82832C (fi) 1982-04-27 1983-04-26 Foerfarande foer framstaellning av terapeutiskt anvaendbara disubstituerade xanten- och xantonderivat.

Country Status (11)

Country Link
US (1) US4902701A (fi)
EP (1) EP0093381B1 (fi)
AU (1) AU566167B2 (fi)
CA (1) CA1222516A (fi)
DE (1) DE3364674D1 (fi)
DK (1) DK185283A (fi)
FI (1) FI82832C (fi)
GR (1) GR78142B (fi)
IE (1) IE55228B1 (fi)
IL (1) IL68498A (fi)
NZ (1) NZ204003A (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8309260D0 (en) * 1983-04-06 1983-05-11 Erba Farmitalia Condensed benzopyrone derivatives
GB8328494D0 (en) * 1983-10-25 1983-11-23 Wellcome Found Liquid containment systems
US4861795A (en) * 1988-06-23 1989-08-29 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
US4849416A (en) * 1988-07-25 1989-07-18 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
IT1261662B (it) * 1992-09-07 1996-05-28 Inverni Della Beffa Spa Derivati xantonici, loro preparazione ed attivita'
US5624794A (en) * 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
EP0795554A3 (en) * 1996-03-05 1998-01-28 Takeda Chemical Industries, Ltd. (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators
US6355153B1 (en) * 1999-09-17 2002-03-12 Nutool, Inc. Chip interconnect and packaging deposition methods and structures
US7506438B1 (en) * 2000-11-14 2009-03-24 Freescale Semiconductor, Inc. Low profile integrated module interconnects and method of fabrication
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
NZ622456A (en) 2009-10-12 2015-09-25 New Health Sciences Inc Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
NZ599890A (en) 2009-10-12 2014-03-28 Univ Pittsburgh Oxygen depletion devices and methods for removing oxygen from red blood cells
EP4091645A1 (en) 2010-08-25 2022-11-23 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
ES2793484T3 (es) 2010-11-05 2020-11-16 Hemanext Inc Irradiación de glóbulos rojos y almacenamiento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013023156A1 (en) 2011-08-10 2013-02-14 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device
EP2961269B1 (en) 2013-02-28 2021-09-15 Hemanext Inc. Gas depletion device for blood products
WO2016145210A1 (en) 2015-03-10 2016-09-15 New Health Sciences, Inc. Oxygen reduction disposable kits, devices and methods of use thereof
KR20240067253A (ko) 2015-04-23 2024-05-16 헤마넥스트 인코포레이티드 혐기성 혈액 저장 용기
AU2016264327B2 (en) 2015-05-18 2021-12-23 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
IL303240A (en) 2016-05-27 2023-07-01 Hemanext Inc Anaerobic blood storage and pathogen inactivation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783246A (en) * 1955-05-02 1957-02-26 Allied Chem & Dye Corp Manufacture of xanthene
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
US4061768A (en) * 1971-09-08 1977-12-06 Burroughs Wellcome Co. Certain cyclic carbonyl compounds used in the prophylaxis of allergic conditions
AU478775B2 (en) * 1974-09-13 1974-12-12 Syntex Gu. S. A. ) Inc Novel substituted xanthone carboxylic acid compounds

Also Published As

Publication number Publication date
FI82832C (fi) 1991-04-25
CA1222516A (en) 1987-06-02
GR78142B (fi) 1984-09-26
AU1392483A (en) 1983-11-03
FI82832B (fi) 1991-01-15
FI831420A0 (fi) 1983-04-26
IL68498A0 (en) 1983-07-31
NZ204003A (en) 1986-05-09
DK185283A (da) 1983-10-28
DK185283D0 (da) 1983-04-26
AU566167B2 (en) 1987-10-08
DE3364674D1 (en) 1986-08-28
EP0093381A1 (en) 1983-11-09
EP0093381B1 (en) 1986-07-23
IE830949L (en) 1983-10-27
IE55228B1 (en) 1990-07-04
IL68498A (en) 1986-09-30
US4902701A (en) 1990-02-20

Similar Documents

Publication Publication Date Title
FI830752L (fi) Karboxialkyldipeptider, foerfaranden foer deras framstaellning och farmaceutiska blandningar innehaollande dessa
FI831591A0 (fi) Azolylmetyloxiraner, deras framstaellningsfoerfarande och dessa innehaollande fungicider
FI830378L (fi) Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel
FI842601A0 (fi) Utdelningsanordning och uppteckningsapparat.
FI831420L (fi) Tricykliska foereningar, deras framstaellning, anvaendning och mellanprodukter
FI833398A (fi) Termiticidala atraktantfoereningar, kompositioner och foerfarande foer deras anvaendning
FI834888A0 (fi) Gonadoliberinderivat, foerfarande foer deras framstaellning och farmaceutiska och veterinaermedicinblandningar framstaellda daerav
FI834430A (fi) Haorfaergningsfoerfarande och faergningskompositionsfoerpackning.
FI834452A (fi) Aromatiska oligomerer och hartser.
FI824126L (fi) Foerfarande i laonghaolbergborrning och borrstaongsystem.
FI830457L (fi) Laosanordning, speciellt foer laemmar till lastflak och dylikt
FI842376A0 (fi) Monoskopisk och stereoskopisk televisionsapparat.
FI831790A0 (fi) Piperazinderivat, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI833818A (fi) Foerfarande foer framstaellning av foerbaettrade formmassor av finfoerdelade expanderbara styrenpolymerisat med belaeggning, och anvaendning av belaeggningsprodukterna
FI831367L (fi) Pleuromutillinderivat, deras framstaellningsfoerfarande och farmaceutiska anvaendning
FI830297L (fi) Benzotiennylallylaminer, foerfarande foer deras producering och deras anvaendning saosom laekemedel
FI832789A0 (fi) Mjoeldrygealkaloider, deras framstaellning och anvaendning
FI833292A0 (fi) Piperidinderivat, deras framstaellning och anvaendning
FI833337A0 (fi) Heterocykliska foereningar, deras framstaellning, dessa innehaollande kompositioner och foerfarandekontrollering av ooenskad tillvaext av vaexter
FI833102A (fi) Substituerade 1-pyridyloxi-3-indolylalkyl-amino-2-propanoler, deras framstaellning och anvaendning
FI830206L (fi) Roterande, gaengfoersedd borrande och gaengbildande skruv
FI830992A0 (fi) 7- -aminoacyl-3-klorkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning solaekemedel
FI821506L (fi) Saekerhetskoppling foer baotar, motorslaedar och liknande
FI823970A0 (fi) Slaeptaetningsmontering foer foenster och motsvarande oeppningsbara byggnadsdelar, baoge och taetninmontering
FI821763A0 (fi) Foerfarande foer anvaendning av gasurladdningslamps drossel, drosselkoppling och drossel

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED